A5036374521- HIV/AIDS Research and Interventions
- HIV, Drug Use, Sexual Risk
- Adolescent Sexual and Reproductive Health
- Food Security and Health in Diverse Populations
- HIV Research and Treatment
- Sex work and related issues
- Homelessness and Social Issues
- Health Policy Implementation Science
- HIV/AIDS drug development and treatment
- HIV-related health complications and treatments
- Health Systems, Economic Evaluations, Quality of Life
- HIV/AIDS Impact and Responses
- Public Health Policies and Education
- COVID-19 Clinical Research Studies
- Opioid Use Disorder Treatment
- Vaccine Coverage and Hesitancy
- Smoking Behavior and Cessation
- Community Health and Development
- SARS-CoV-2 and COVID-19 Research
- COVID-19 epidemiological studies
- Health disparities and outcomes
- Healthcare Policy and Management
- Poisoning and overdose treatments
- Poverty, Education, and Child Welfare
- Healthcare cost, quality, practices
University at Albany, State University of New York
2018-2024
New York State Department of Health
2024
Bloomberg (United States)
2024
Public Health Department
2024
The White House
2022-2024
Johns Hopkins University
2011-2022
Albany State University
2018-2022
Rockefeller University
2021
AIDS United
2015-2017
Sidney Kimmel Comprehensive Cancer Center
2017
Hydroxychloroquine, with or without azithromycin, has been considered as a possible therapeutic agent for patients coronavirus disease 2019 (COVID-19). However, there are limited data on efficacy and associated adverse events.To describe the association between use of hydroxychloroquine, clinical outcomes among hospital inpatients diagnosed COVID-19.Retrospective multicenter cohort study from random sample all admitted laboratory-confirmed COVID-19 in 25 hospitals, representing 88.2% New...
In the United States, HIV prevention programs have historically tailored activities for specific groups primarily on basis of behavioral risk factors and demographic characteristics. Through Serostatus Approach to Fighting Epidemic (SAFE), Centers Disease Control Prevention is now expanding programs, especially individuals with HIV, reduce transmission as a supplement current that focus reducing acquisition virus. For SAFE comprises action steps diagnosing all HIV-infected persons, linking...
Public health researchers are addressing new research questions (e.g., effects of environmental tobacco smoke, Hurricane Katrina) for which the randomized controlled trial (RCT) may not be a feasible option. Drawing on potential outcomes framework (Rubin Causal Model) and Campbellian perspectives, we consider alternative designs that permit relatively strong causal inferences. In encouragement designs, participants randomly invited to participate in one treatment conditions, but allowed...
New York State has been an epicenter for both the US coronavirus disease 2019 (COVID-19) and HIV/AIDS epidemics. Persons living with diagnosed HIV may be more prone to COVID-19 infection severe outcomes, yet few studies have assessed this possibility at a population level.To evaluate association between diagnosis diagnosis, hospitalization, in-hospital death in State.This cohort study, conducted State, including City, March 1 June 15, 2020, matched data from surveillance,...
Early diagnosis of human immunodeficiency virus (HIV) infection, prompt linkage to and sustained care, antiretroviral therapy are associated with reduced individual morbidity, mortality, transmission the virus. However, levels these indicators may differ among population groups HIV. Disparities in care treatment contribute higher incidence rates prevalence HIV.To examine differences between persons living HIV by sex, age, race/ethnicity, category at essential steps continuum care.We obtained...
Data from randomized clinical trials and real-world observational studies show that all three COVID-19 vaccines currently authorized for emergency use by the Food Drug Administration* are safe highly effective preventing COVID-19-related serious illness, hospitalization, death (1,2). Studies of vaccine effectiveness (VE) new infections hospitalizations attributable to SARS-CoV-2, virus causes COVID-19), particularly as B.1.617.2 (Delta) variant has become predominant, limited in United...
Abstract Background The US’ coronavirus disease 2019 (COVID-19) epidemic has grown extensively since February 2020, with substantial associated hospitalizations and mortality; New York State emerged as the national epicenter. We report on extent of testing test results during month March in State, along risk factors, outcomes, household prevalence among initial cases subject to in-depth investigations. Methods Specimen collection for COVID-19 was conducted healthcare settings,...
Data from randomized clinical trials and real-world observational studies show that all three COVID-19 vaccines currently authorized for emergency use by the Food Drug Administration* are safe highly effective preventing COVID-19-related serious illness, hospitalization, death (1,2). Studies of vaccine effectiveness (VE) new infections hospitalizations attributable to SARS-CoV-2, virus causes COVID-19), particularly as B.1.617.2 (Delta) variant has become predominant, limited in United...
<b>Background:</b> Social capital has been related to a number of important public health variables such as child welfare, mortality, and status. However, the relation social <i>infectious</i> diseases received relatively little attention. The measures is often posited be key societal poverty income inequality. Therefore, any exploration correlation between infectious should also include examination association with <b>Objective:</b> This study examined state level capital, poverty,...
To allocate limited economic and other resources for HIV prevention treatment maximum benefit, health policy planners decision makers require accurate, current estimates of the lifetime costs HIV-related illness impact therapy on quality life HIV-infected persons. These data are central input parameters to evaluation methodology known as cost-utility analysis. The available in literature already outdated, this paper presents updated projected care associated with disease United States number...
AIDS service organizations (ASOs) rarely have access to the information needed implement research-based HIV prevention interventions for their clients. We compared effectiveness of 3 dissemination strategies transferring models from research arena community providers services.Interviews were conducted with directors 74 ASOs assess current services. randomized programs that provided (1) technical assistance manuals describing how interventions, (2) plus a staff training workshop on conduct...
There has been increasing emphasis on care and treatment for persons with human immunodeficiency virus (HIV) in the United States during past decade,, including use of antiretroviral therapy survival decreasing transmission. Accurate HIV diagnosis data recently became available all states, allowing first time an examination long-term national trends. These can be used to monitor awareness serostatus among living HIV, primary prevention efforts, testing initiatives. We examined trends...
Emerging data warrant the integration of biomedical and behavioral recommendations for human immunodeficiency virus (HIV) prevention in clinical care settings.
LGBT (lesbian, gay, bisexual, and transgender) populations experience disparities in health outcomes, both physical mental, compared to their heterosexual cisgender peers. This commentary confronts the view held by some researchers that disparate rates of mental problems reported among are consequences pursuing a particular life trajectory, rather than resulting from corrosive persistent impact stigma. Suggesting arise internally, de novo, when individuals express non-heterosexual...